[Clinical application of a new nasolacrimal stent].
Seventy-two patients(ninety-one eyes) with epiphore due to obstruction of the nasolacrimal duct underwent nasolacrimal stent of our own disign. The period postoperative follow-up was 6 to 20(mean 14.5) months. Seventy-six eyes demonstrated obvious resolution of epiphore, twelve eyes had partial resolution, and three eyes had no resolution. The success rate were 96.7%. The common complications included occluded stent and a slightly blood-stanied nasal discharge. The placement of the nasolacrimal stent is a safe simple and effective method for treatment of epiphore due to obstruction of the nasolacrimal duct.
Xiao
M Y
MY
Department of Ophthalmology, Second Xiangya Hospital, Central South University, Changsha 410011, China.
Zhang
Z S
ZS
D000328:Adult; D003607:Dacryocystitis / Q000628:therapy*; D005260:Female; D006801:Humans; D007766:Lacrimal Apparatus Diseases / Q000628:therapy*; D007767:Lacrimal Duct Obstruction / Q000628:therapy; D008297:Male; D008875:Middle Aged; D015607:Stents